Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects

被引:0
作者
De Vries, R
Wolffenbuttel, BHR
Sluiter, WJ
Van Tol, A
Dullaart, RPF
机构
[1] Univ Groningen, Med Ctr, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands
关键词
adiponectin; HDL cholesterol; hepatic lipase; lipoprotein lipase; triglycerides; type 2 diabetes mellitus;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The aim of this study was to determine the relationships of plasma adiponectin with post-heparin plasma lipoprotein lipase (LPL) and hepatic lipase (HL) activities, and to evaluate whether plasma adiponectin contributes to diabetes-associated dyslipidaemia. Plasma adiponectin, post-heparin plasma lipase activities, lipoproteins and insulin sensitivity (hyperinsulinaemic euglycaemic clamp) were measured in 24 male type 2 diabetic patients and 24 age-matched healthy men. Plasma triglycerides (P < 0.01) and apolipoprotein B levels (P < 0.01) were higher, and HDL cholesterol was lower (P < 0.05) in type 2 diabetic patients. Plasma adiponectin, as well as LPL and HL activities were not significantly different between diabetic and healthy subjects. Multiple regression analysis showed that LPL activity was positively related with plasma adiponectin (P < 0.05). In contrast, HL activity was positively related with body mass index (P < 0.02) and waist/hip ratio (P < 0.05, multiple r = 0.74), but not with plasma adiponectin. Plasma adiponectin was positively associated with insulin sensitivity (P = 0.001), age (P < 0.02) and LPL activity (P < 0.05, multiple r = 0.64), but not with the presence of diabetes and HL activity. Plasma triglycerides were negatively related with LPL activity (P = 0.002) and positively with the diabetic state (P = 0.001, multiple r = 0.58). HDL cholesterol was positively related with plasma adiponectin (P = 0.003) and negatively with HL activity (P < 0.02) as well as with the presence of diabetes (P = 0.05, multiple r = 0.59). We conclude that post-heparin plasma LPL activity, but not HL activity, is related with plasma adiponectin. Plasma adiponectin appears to be a determinant of plasma triglycerides via an effect on LPL activity. It seems unlikely that plasma adiponectin predicts the effects of the diabetic state as such on high plasma triglycerides and low HDL cholesterol.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 41 条
  • [31] Blockade of the renin-angiotensin system increases plasma adiponectin levels in type-2 diabetic patients with proteinuria
    Yenicesu, M
    Yilmaz, MI
    Caglar, K
    Sonmez, A
    Eyileten, T
    Acikel, C
    Kilic, S
    Bingol, N
    Bingol, S
    Vural, A
    NEPHRON CLINICAL PRACTICE, 2005, 99 (04): : C115 - C121
  • [32] The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients
    Kobayashi, J.
    Nakajima, K.
    Nohara, A.
    Kawashiri, M.
    Yagi, K.
    Inazu, A.
    Koizumi, J.
    Yamagishi, M.
    Mabuchi, H.
    HORMONE AND METABOLIC RESEARCH, 2007, 39 (08) : 612 - 616
  • [33] Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria
    Mahmut Ilker Yilmaz
    Alper Sonmez
    Kayser Caglar
    Deniz Engin Gok
    Tayfun Eyileten
    Müjdat Yenicesu
    Cengizhan Acikel
    Necati Bingol
    Selim Kilic
    Yusuf Oguz
    Abdulgaffar Vural
    Endocrine, 2004, 25 : 207 - 214
  • [34] Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria
    Yilmaz, MI
    Sonmez, A
    Caglar, K
    Gok, DE
    Eyileten, T
    Yenicesu, M
    Acikel, C
    Bingol, N
    Kilic, S
    Oguz, Y
    Vural, A
    ENDOCRINE, 2004, 25 (03) : 207 - 214
  • [35] Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes
    Thamer, C.
    Haap, M.
    Heller, E.
    Joel, L.
    Braun, S.
    Tschritter, O.
    Haring, H.
    Fritsche, A.
    HORMONE AND METABOLIC RESEARCH, 2006, 38 (03) : 178 - 182
  • [36] Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes
    Dullaart, RPF
    Riemens, SC
    Scheek, LM
    van Tol, A
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1999, 29 (08) : 663 - 671
  • [37] Effect of Ethnicity, (D)ietary Intake and Physical Activity on Plasma Adiponectin Concentrations Among Malaysian Patients with Type 2 Diabetes Mellitus
    Chin, Koo Hui
    Sathyasurya, Daniel Robert
    Abu Saad, Hazizi
    Mohamed, Hamid Jan B. Jan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 11 (03) : 167 - 174
  • [38] Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients
    Riemens, SC
    van Tol, A
    Sluiter, WJ
    Dullaart, RPF
    DIABETOLOGIA, 1998, 41 (08) : 929 - 934
  • [39] Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients
    S. C. Riemens
    A. van Tol
    W. J. Sluiter
    R. P. F. Dullaart
    Diabetologia, 1998, 41 : 929 - 934
  • [40] Low density lipoprotein receptor–related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels
    L. Nasarre
    O. Juan-Babot
    P. Gastelurrutia
    A. Llucia-Valldeperas
    L. Badimon
    A. Bayes-Genis
    V. Llorente-Cortés
    Acta Diabetologica, 2014, 51 : 23 - 30